Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
INFI > SEC Filings for INFI > Form 8-K on 4-Jun-2013All Recent SEC Filings

Show all filings for INFINITY PHARMACEUTICALS, INC. | Request a Trial to NEW EDGAR Online Pro



Other Events, Financial Statements and Exhibits

Item 8.01. Other Events

On June 2, 2013 and June 3, 2013 we issued press releases announcing new data from our ongoing Phase 1, open-label, clinical trial of IPI-145, our potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies. A copy of each of these press releases is filed as Exhibits 99.1 and 99.2, respectively, and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) The following exhibits are included in this report:

  No.                                     Description

99.1         Press release dated June 2, 2013, entitled Infinity Reports Updated
             Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in
             Chronic Lymphocytic Leukemia at ASCO Annual Meeting.

99.2         Press release dated June 3, 2013, entitled Infinity Reports Updated
             Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in
             B-Cell and T-Cell Lymphomas at ASCO Annual Meeting and Announces
             Initiation of Phase 2 Clinical Study in Indolent Non-Hodgkin Lymphoma.

  Add INFI to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for INFI - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.